637 related articles for article (PubMed ID: 33681329)
1. From Conventional to Precision Therapy in Canine Mammary Cancer: A Comprehensive Review.
Valdivia G; Alonso-Diez Á; Pérez-Alenza D; Peña L
Front Vet Sci; 2021; 8():623800. PubMed ID: 33681329
[TBL] [Abstract][Full Text] [Related]
2. Hormonal Homologies between Canine Mammary Cancer and Human Breast Cancer in a Series of Cases.
de Andrés PJ; Cáceres S; Illera JC; Crespo B; Silván G; Queiroga FL; Illera MJ; Pérez-Alenza MD; Peña L
Vet Sci; 2022 Jul; 9(8):. PubMed ID: 36006309
[TBL] [Abstract][Full Text] [Related]
3. Canine Mammary Carcinomas: A Comparative Analysis of Altered Gene Expression.
Lutful Kabir FM; Alvarez CE; Bird RC
Vet Sci; 2015 Dec; 3(1):. PubMed ID: 29056711
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.
Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T
BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842
[TBL] [Abstract][Full Text] [Related]
5. Hormone, Targeted, and Combinational Therapies for Breast Cancers: From Humans to Dogs.
Ke CH; Lin CN; Lin CS
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255807
[TBL] [Abstract][Full Text] [Related]
6. Non-Exosomal and Exosome-Derived miRNAs as Promising Biomarkers in Canine Mammary Cancer.
Petroušková P; Hudáková N; Maloveská M; Humeník F; Cizkova D
Life (Basel); 2022 Apr; 12(4):. PubMed ID: 35455015
[TBL] [Abstract][Full Text] [Related]
7. Canine Mammary Tumors: Classification, Biomarkers, Traditional and Personalized Therapies.
Nosalova N; Huniadi M; Horňáková Ľ; Valenčáková A; Horňák S; Nagoos K; Vozar J; Cizkova D
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474142
[TBL] [Abstract][Full Text] [Related]
8. The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study.
Jaillardon L; Abadie J; Godard T; Campone M; Loussouarn D; Siliart B; Nguyen F
BMC Cancer; 2015 Oct; 15():664. PubMed ID: 26449867
[TBL] [Abstract][Full Text] [Related]
9. Canine mammary tumors as a model for human disease.
Abdelmegeed SM; Mohammed S
Oncol Lett; 2018 Jun; 15(6):8195-8205. PubMed ID: 29928319
[TBL] [Abstract][Full Text] [Related]
10. ZEB1 and ZEB2 transcription factors are potential therapeutic targets of canine mammary cancer cells.
Xavier PLP; Cordeiro YG; Rochetti AL; Sangalli JR; Zuccari DAPC; Silveira JC; Bressan FF; Fukumasu H
Vet Comp Oncol; 2018 Dec; 16(4):596-605. PubMed ID: 30047225
[TBL] [Abstract][Full Text] [Related]
11. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
12. Triple-Negative Breast Cancer Comparison With Canine Mammary Tumors From Light Microscopy to Molecular Pathology.
Amirkhani Namagerdi A; d'Angelo D; Ciani F; Iannuzzi CA; Napolitano F; Avallone L; De Laurentiis M; Giordano A
Front Oncol; 2020; 10():563779. PubMed ID: 33282730
[TBL] [Abstract][Full Text] [Related]
13. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-124 inhibits canine mammary carcinoma cell proliferation, migration and invasion by targeting CDH2.
Ren X; Fan Y; Shi D; Xu E; Liu Y
Res Vet Sci; 2022 Sep; 146():5-14. PubMed ID: 35290861
[TBL] [Abstract][Full Text] [Related]
15. Comparison of mucin-1 in human breast cancer and canine mammary gland tumor: a review study.
Vafaei R; Samadi M; Hosseinzadeh A; Barzaman K; Esmailinejad M; Khaki Z; Farahmand L
Cancer Cell Int; 2022 Jan; 22(1):14. PubMed ID: 35000604
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors.
Rao NA; van Wolferen ME; Gracanin A; Bhatti SF; Krol M; Holstege FC; Mol JA
J Physiol Pharmacol; 2009 May; 60 Suppl 1():73-84. PubMed ID: 19609016
[TBL] [Abstract][Full Text] [Related]
17. Canine mammary tumors: a review and consensus of standard guidelines on epithelial and myoepithelial phenotype markers, HER2, and hormone receptor assessment using immunohistochemistry.
Peña L; Gama A; Goldschmidt MH; Abadie J; Benazzi C; Castagnaro M; Díez L; Gärtner F; Hellmén E; Kiupel M; Millán Y; Miller MA; Nguyen F; Poli A; Sarli G; Zappulli V; de las Mulas JM
Vet Pathol; 2014 Jan; 51(1):127-45. PubMed ID: 24227007
[TBL] [Abstract][Full Text] [Related]
18. Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: is the dog a suitable animal model for human breast cancer?
Burrai GP; Tanca A; De Miglio MR; Abbondio M; Pisanu S; Polinas M; Pirino S; Mohammed SI; Uzzau S; Addis MF; Antuofermo E
Tumour Biol; 2015 Nov; 36(11):9083-91. PubMed ID: 26088453
[TBL] [Abstract][Full Text] [Related]
19. Contraceptive steroid toxicology in the Beagle dog and its relevance to human carcinogenicity.
Owen LN; Briggs MH
Curr Med Res Opin; 1976; 4(5):309-29. PubMed ID: 64332
[TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of a new triple-negative canine mammary cancer cell line.
Zhang H; Pei S; Zhou B; Wang H; Du H; Zhang D; Lin D
Tissue Cell; 2018 Oct; 54():10-19. PubMed ID: 30309498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
